Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasaflex (Mometasone/Azelastine) in Perennial Allergic Rhinitis
NCT01470053Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Mar 2011
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone, azelastine in perennial allergic rhinitis (PAR), sponsored by Hanlim Pharm. Started Mar 2011; status: completed.
02
Drugs
mometasoneazelastine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01470053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470053.